SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001005201-19-000112
Filing Date
2019-10-01
Accepted
2019-10-01 17:12:49
Documents
2
Period of Report
2019-09-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_156996434611744.html 3  
1 FORM 3 wf-form3_156996434611744.xml 3 2263
2 WHEADON POA a1powerofattorneyforsec16-.htm EX-24 3278
  Complete submission text file 0001005201-19-000112.txt   7064
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Issuer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ASSERTIO THERAPEUTICS, INC. 100 SOUTH SAUNDERS ROAD, SUITE 300 LAKE FOREST IL 60045
Business Address
Wheadon David E. (Reporting) CIK: 0001789507 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-13111 | Film No.: 191129893